Whitener Capital Management, Inc. Ligand Pharmaceuticals Inc Transaction History

Whitener Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$86.25 - $120.16 $8,625 - $12,016	-100 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$105.93 - $142.47 $5,296 - $7,123	50 Added 100.0%	100 $12,000
Q3 2018 Nov 07, 2018	BUY	$211.18 - $274.49 $10,559 - $13,724	50 New	50 $13,000
Q2 2018 Aug 08, 2018	SELL	$150.77 - $207.98 $7,538 - $10,399	-50 Closed	0 $0
Q4 2017 Apr 23, 2018	BUY	$128.36 - $147.04 $6,418 - $7,352	50	50 $6,000

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.